Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AKT-022 by Aquavit Pharmaceuticals for Unspecified Dermatological Disorders: Likelihood of Approval
AKT-022 is under clinical development by Aquavit Pharmaceuticals and currently in Phase III for Unspecified Dermatological Disorders. According to GlobalData,...